The Human Microbiome is a Source of Therapeutic Drug Targets

Symberix Co-Founder Matthew Redinbo and Senior Scientist Bret Wallace review the roles that symbiotic bacteria play in the chemistry of human health, with a focus on the emerging appreciation that specific enzyme targets can be selectively disrupted to achieve clinical outcomes.